TRCT
ACHC icon

Tower Research Capital (TRC)’s Acadia Healthcare ACHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.7K Sell
1,098
-9,229
-89% -$167K ﹤0.01% 3305
2025
Q4 		$147K Buy
10,327
+4,631
+81% +$87.6K ﹤0.01% 1677
2025
Q3 		$141K Sell
5,696
-25,718
-82% -$574K ﹤0.01% 1744
2025
Q2 		$713K Buy
31,414
+27,146
+636% +$643K 0.02% 716
2025
Q1 		$129K Sell
4,268
-27,674
-87% -$1.05M ﹤0.01% 1628
2024
Q4 		$1.27M Buy
31,942
+8,560
+37% +$386K 0.03% 518
2024
Q3 		$1.48M Buy
23,382
+19,929
+577% +$1.44M 0.04% 365
2024
Q2 		$233K Buy
3,453
+605
+21% +$42.2K ﹤0.01% 1948
2024
Q1 		$226K Sell
2,848
-8,793
-76% -$719K 0.01% 1339
2023
Q4 		$905K Buy
11,641
+1,352
+13% +$100K 0.01% 917
2023
Q3 		$723K Buy
10,289
+5,065
+97% +$378K 0.02% 684
2023
Q2 		$416K Sell
5,224
-12,177
-70% -$880K 0.01% 1097
2023
Q1 		$1.26M Buy
17,401
+15,547
+839% +$1.21M 0.04% 342
2022
Q4 		$152K Sell
1,854
-1,811
-49% -$149K 0.01% 1501
2022
Q3 		$287K Sell
3,665
-2,822
-44% -$226K ﹤0.01% 1584
2022
Q2 		$438K Sell
6,487
-3,754
-37% -$262K 0.01% 1222
2022
Q1 		$671K Buy
10,241
+4,002
+64% +$232K 0.01% 986
2021
Q4 		$379K Buy
6,239
+1,829
+41% +$109K 0.01% 1309
2021
Q3 		$281K Sell
4,410
-2,537
-37% -$160K 0.01% 1473
2021
Q2 		$436K Sell
6,947
-6,447
-48% -$404K 0.01% 1295
2021
Q1 		$765K Sell
13,394
-10,433
-44% -$565K 0.01% 916
2020
Q4 		$1.2M Sell
23,827
-4,471
-16% -$178K 0.04% 417
2020
Q3 		$834K Buy
28,298
+2,308
+9% +$67K 0.01% 1157
2020
Q2 		$653K Buy
25,990
+22,316
+607% +$557K 0.03% 804
2020
Q1 		$67K Sell
3,674
-797
-18% -$22.8K ﹤0.01% 1148
2019
Q4 		$149K Buy
4,471
+3,754
+524% +$118K 0.01% 736
2019
Q3 		$22K Sell
717
-5,863
-89% -$179K ﹤0.01% 2394
2019
Q2 		$230K Buy
6,580
+1,038
+19% +$33.6K 0.02% 810
2019
Q1 		$163K Buy
+5,542
New +$157K 0.01% 1217
2018
Q4 		– Sell
-8,786
Closed -$310K – 3770
2018
Q3 		$310K Buy
8,786
+5,323
+154% +$212K 0.02% 740
2018
Q2 		$141K Sell
3,463
-10,528
-75% -$425K 0.01% 1229
2018
Q1 		$548K Buy
13,991
+12,967
+1,266% +$475K 0.05% 430
2017
Q4 		$34K Buy
1,024
+882
+621% +$30.6K ﹤0.01% 1626
2017
Q3 		$7K Buy
142
+114
+407% +$5.56K ﹤0.01% 3191
2017
Q2 		$1K Sell
28
-393
-93% -$17.4K ﹤0.01% 2452
2017
Q1 		$18K Buy
421
+381
+953% +$15.5K ﹤0.01% 1353
2016
Q4 		$1K Sell
40
-1,061
-96% -$41.2K ﹤0.01% 3554
2016
Q3 		$55K Buy
1,101
+924
+522% +$48.1K 0.01% 1092
2016
Q2 		$10K Buy
+177
New +$10.4K ﹤0.01% 2782
2015
Q4 		– Sell
-187
Closed -$12K – 4400
2015
Q3 		$12K Sell
187
-2,068
-92% -$159K ﹤0.01% 2137
2015
Q2 		$177K Sell
2,255
-1,390
-38% -$100K 0.02% 435
2015
Q1 		$261K Buy
+3,645
New +$234K 0.03% 300
2014
Q4 		– Sell
-2,412
Closed -$117K – 3944
2014
Q3 		$117K Buy
2,412
+2,251
+1,398% +$110K 0.01% 806
2014
Q2 		$7K Sell
161
-88
-35% -$3.87K ﹤0.01% 2592
2014
Q1 		$11K Sell
249
-185
-43% -$9.13K ﹤0.01% 2488
2013
Q4 		$21K Sell
434
-2,815
-87% -$122K ﹤0.01% 2268
2013
Q3 		$129K Sell
3,249
-4,499
-58% -$167K 0.01% 1078
2013
Q2 		$256K Buy
+7,748
New +$251K 0.02% 207

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tower Research Capital (TRC)'s ACHC Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Acadia Healthcare (ACHC) stake by 89% in Q1 2026, selling an estimated $167K and leaving 1,098 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3305.

Tower Research Capital (TRC) first reported a position in ACHC in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.48M in Q3 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Tower Research Capital (TRC) held 1,098 shares of Acadia Healthcare worth $25.7K as of Q1 2026.
  • Tower Research Capital (TRC) sold 9,229 Acadia Healthcare shares in Q1 2026, an estimated $167K.
  • Acadia Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3305 holding.
  • Tower Research Capital (TRC) first reported a position in Acadia Healthcare in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Acadia Healthcare position peaked at $1.48M in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.